2025 Global Apheresis Market Revenue Opportunities Report
Description
The 2025 Global Apheresis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global apheresis market are Fresenius SE & Co. KGaA, Asahi Kasei Corporation, Haemonetics Corporation, and Terumo Corporation (Terumo BCT Inc.). These companies hold dominant positions by innovating and launching advanced apheresis technologies, contributing to the market valued around USD 2.7-3.7 billion in 2024-2025, with steady growth forecasts through 2030 and beyond. Fresenius, a Germany-based firm, focuses heavily on dialysis and apheresis technology development, including recent investment in new production facilities. Asahi Kasei Medical, originating from Japan, expanded by integrating bioprocessing capabilities in China. Haemonetics and Terumo, both U.S.-based, lead in device innovations and have formed significant collaborations and regulatory partnerships to advance therapeutic apheresis treatments.
These companies continuously foster collaborations with healthcare institutions, research centers, and regulatory bodies to expand applications of apheresis technology in chronic disease management, plasma collection, and surgical procedures. Terumo’s Spectra Optia system is deployed widely in NHS hospitals in the UK to improve sickle cell disease treatment access. Fresenius and Terumo have introduced next-generation platforms emphasizing efficiency and patient comfort, reflecting their leadership in advancing personalized and cutting-edge apheresis therapies globally. North America remains the largest market region, supported by high demand for blood components and chronic disease prevalence, while Asia-Pacific shows the fastest growth driven by healthcare expansion and government initiatives.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global apheresis market are Fresenius SE & Co. KGaA, Asahi Kasei Corporation, Haemonetics Corporation, and Terumo Corporation (Terumo BCT Inc.). These companies hold dominant positions by innovating and launching advanced apheresis technologies, contributing to the market valued around USD 2.7-3.7 billion in 2024-2025, with steady growth forecasts through 2030 and beyond. Fresenius, a Germany-based firm, focuses heavily on dialysis and apheresis technology development, including recent investment in new production facilities. Asahi Kasei Medical, originating from Japan, expanded by integrating bioprocessing capabilities in China. Haemonetics and Terumo, both U.S.-based, lead in device innovations and have formed significant collaborations and regulatory partnerships to advance therapeutic apheresis treatments.
These companies continuously foster collaborations with healthcare institutions, research centers, and regulatory bodies to expand applications of apheresis technology in chronic disease management, plasma collection, and surgical procedures. Terumo’s Spectra Optia system is deployed widely in NHS hospitals in the UK to improve sickle cell disease treatment access. Fresenius and Terumo have introduced next-generation platforms emphasizing efficiency and patient comfort, reflecting their leadership in advancing personalized and cutting-edge apheresis therapies globally. North America remains the largest market region, supported by high demand for blood components and chronic disease prevalence, while Asia-Pacific shows the fastest growth driven by healthcare expansion and government initiatives.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
